NDAINHALATIONAEROSOL, METERED
Approved
Sep 1992
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
3
Data completeness
3/8 — Basic
BRONCHO SALINE (sodium chloride) by Fresenius Kabi is clinical pharmacology 3% and 5% sodium chloride injection, usp has value as a source of water and electrolytes. First approved in 1992.
Drug data last refreshed 1w ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
BRONCHO SALINE is a 3% and 5% sodium chloride inhalation aerosol used to deliver electrolyte-rich saline directly to the respiratory tract. It functions as a source of water and electrolytes capable of inducing diuresis and mucosal hydration. The product is indicated for patients requiring bronchial hygiene and airway clearance support.
LOE Approaching
As LOE approaches, the commercial team is likely in optimization and cost-efficiency mode with potential headcount consolidation or transition focus toward line extensions or repositioning strategies.
Mechanism of Action
CLINICAL PHARMACOLOGY 3% and 5% Sodium Chloride Injection, USP has value as a source of water and electrolytes. It is capable of inducing diuresis depending on the clinical condition of the patient.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (3)
Study to Evaluate the Efficacy and Safety of Intravenous Infusion With Nemonoxacin Malate Sodium Chloride
Started Mar 2013
207 enrolled
Pneumonia
Tetraspan 6 Percent (%) Combined With Sterofundin ISO Versus Albumin 5 Percent (%) Combined With Sodium Chloride (NaCL)
Started Nov 2009
2 enrolled
Renal Insufficiency
A Study of Nemonoxacin Malate Sodium Chloride Injection Administered by Intravenous Infusion
Started Sep 2008
176 enrolled
Healthy
Career Relevance
Working on BRONCHO SALINE offers limited growth opportunity given its LOE-approaching lifecycle and minimal linked job openings (0 reported). Career progression is best suited for professionals focused on operational excellence, cost management, and mature-product optimization rather than innovation and market expansion.
Worked on BRONCHO SALINE at Fresenius Kabi? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.